Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Status:
Unknown status
Trial end date:
2020-09-25
Target enrollment:
Participant gender:
Summary
This phase I trial will assess primarily the safety and secondarily anti-inflammatory effect
of Episcleral Dexamethasone in patients suffering from macular edema and other disorders of
the retina, choroid and vitreous.